1 Product identity
Ingredient risk
1 ingredient to use with caution
Glucosamine Chondroitin + D3 1000 IU Triple Strength
BrandCVS Pharmacy→Other Combinations Other (e.g. tea bag) 10 ingredients 1 caution DSLD #25909Net contents: 120 Caplet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-09-25
2 Ingredients (10)
IngredientGroupSafety
CaloriesCalories—
Total CarbohydratesCarbohydrate—
Dietary FiberFiber (unspecified)—
CelluloseCellulose—
CrospovidoneCrospovidone—
Contains Less Than 2% ofBlend—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
3 Safety cross-reference
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Chloride — Limited Evidence
⚠ Co-ingested with sodium
Chondroitin — Limited Evidence
⚠ May enhance anticoagulants
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID25909
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-09-25
6 More from CVS Pharmacy
View CVS Pharmacy Safety Scorecard → 86 products
A 8,000 IUAdult 50+ ProbioticAdult ProbioticAdvanced Eye HealthAdvanced Formula Glucosamine Chondroitin Triple Strength With UnivestinAlgal-900 DHA7 Cite this page
Vancouver
Pkhakadze G. Glucosamine Chondroitin + D3 1000 IU Triple Strength — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/glucosamine-chondroitin-d3-1000-iu-triple-strength-25909/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG